Efficacy of a Transdiagnostic Group Treatment for Emotional Disorders Applied in Blended Format: a Controlled Study.

Launched by UNIVERSITAT JAUME I · Oct 5, 2022

Keywords

ClinConnect Summary

This clinical trial is studying two different ways to treat emotional disorders like anxiety and depression. Researchers want to see how effective a blended group treatment (which combines online and in-person sessions) is compared to a traditional in-person group treatment. The goal is to find out if both methods can help people feel better, how likely participants are to stick with the program, and how well they accept each treatment style. They will also track whether the improvements last over time.

To participate, you need to be at least 18 years old, have a diagnosed emotional disorder, and understand Spanish. You should also have access to the internet and an email address. However, if you have a severe mental illness, are at high risk of suicide, or are receiving other treatments during the study, you may not be eligible. If you join, you can expect to engage in either the blended or face-to-face treatment and help researchers learn more about how these therapies work. This study is not yet recruiting participants, but it aims to provide valuable insights into effective treatments for emotional disorders.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Being 18 years old or more.
• • DSM-5 (APA, 1013) diagnostic criteria for emotional disorder (panic disorder, agoraphobia, social anxiety disorder, generalized anxiety disorder, major depressive disorder, dysthymia, obsessive-compulsive disorder, non-specified anxiety disorder, non-specified depressive disorder).
• • Good understanding of Spanish.
• • Access to the Internet and email address.
• • Informed consent to participate.
• Exclusion Criteria:
• • Diagnosis of a severe mental disorder (psychotic disorder, bipolar disorder, substance and/or alcohol dependence).
• • High risk of suicide.
• • Having a serious medical illness or other condition that prevents treatment from being carried out.
• • Receiving another psychological treatment during the study period.
• • Changes and/or increases in pharmacological treatment during the study period (a decrease is accepted).